Loading...
The Financial Express

First human trials of coronavirus vaccine within days

As deadly coronavirus continues to spread across the globe, strategies...

WHO, other experts say no evidence of coronavirus losing potency

World Health Organization (WHO) experts and a range of other...

India approves emergency use of remdesivir

India's government said on Tuesday it has approved Gilead Sciences...

Distancing and masks cut COVID-19 risk: Review

Keeping at least one metre apart and wearing face masks...

BD experts advise against using unproven drugs to treat COVID-19

As the search for a remedy to COVID-19 continues in...

New coronavirus losing potency, top Italian doctor says

The new coronavirus is losing its potency and has become...

GP completes handover of 50,000 PPE

As a part of Grameenphone’s COVID-19 responses to support the...

Chinese COVID-19 vaccine could be ready by year-end

A Chinese-made coronavirus vaccine could be ready for market as...

Coronavirus infection rate may shift toward younger ages

The following is a brief roundup of some of the...

Trump cutting US ties with WHO over coronavirus

The United States will end its relationship with the World...

Inside a COVID-19 hospital in India, doctors see no end in sight

It was barely noon on Thursday when the metal doors...

Rotary initiative "Meals Everyday" programme continues

Essential food items under Rotary International Bangladesh's 'Meals Everyday' are...

Novartis Bangladesh donates 28 thousand PPE

Swiss-based leading pharmaceutical company Novartis (Bangladesh) Limited has donated 28,000...

‘Poor countries should boost local pharmaceutical production’

COVID-19 outbreak has heightened the need to boost pharmaceutical production...

Pandemic halts vaccination for nearly 80 million children

The coronavirus pandemic is interrupting immunisation against diseases including measles,...

G20 urged to put public health at core of COVID-19 recovery

Over 40 million doctors, nurses, and other health professionals from...

CanSino coronavirus vaccine appears safe in first human trial

A coronavirus vaccine tested for the first time in humans is safe and induces a rapid immune response, researchers at China's CanSino Biologics Inc reported on Friday in The Lancet medical journal. Blood samples from a group of 108 vaccinated adults showed both neutralising antibodies and T-cell responses against the...